Zurich-based preventive healthcare company Aeon has completed a seed extension round and, at the same time, acquired German blood diagnostics platform Aware Health, according to EU-Startups. Following the deal, Aeon’s total seed funding has risen to more than €12 million, or about $14 million. The round was co-led by Araya Ventures, with existing investors Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm Ventures, N&V Capital, and Bigwave Capital also participating. The update combines fresh financing with an acquisition, tying the capital raise directly to Aeon’s latest expansion move. The announcement identifies Aeon as a preventive healthcare company based in Zurich and Aware Health as a blood diagnostics platform in Germany. No additional transaction terms were disclosed in the source material.
Zurich-based preventive healthcare company Aeon said it has completed a seed extension round and simultaneously acquired German blood diagnostics platform Aware Health, according to EU-Startups.
With the transaction, Aeon’s total seed funding now exceeds €12 million, or about $14 million.
The round was co-led by Araya Ventures. Existing investors Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm Ventures, N&V Capital, and Bigwave Capital also joined the financing.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
